The Latest Cardiac and Vascular News
LIVERMORE, Calif., Jan. 17, 2025 /PRNewswire/ — Advanced Bifurcation Systems Inc. (ABS), a leader in innovative solutions for bifurcation lesions in coronary angioplasty, announces the successful closure of a $20.8 million Simple Agreement for Future Equity (SAFE) financing round. The…
LIVERMORE, Calif., Oct. 23, 2023 /PRNewswire/ — Advanced Bifurcation Systems Inc. (ABS), a pioneer in comprehensive solutions for bifurcation lesions in coronary angioplasty, today announced that it has received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its novel coronary artery bifurcation stenting technology. This prestigious designation is granted to devices that […]
LIVERMORE, Calif., Dec. 16, 2020 /PRNewswire/ — Advanced Bifurcation Systems, Inc. (ABS), a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically designed to efficiently treat coronary bifurcation lesions, is pleased to announce the first closing of an $11 million Series A equity financing. The round was led by Cedars-Sinai, an internationally renowned academic […]
LOS ANGELES, Jan. 25, 2018 (GLOBE NEWSWIRE) — Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced the addition of Thomas O’Neill to the Board of Directors. Mr. O’Neill is […]
Published: Jan 05, 2018 Los Angeles –January 4, 2017 – Advanced Bifurcation Systems (ABS) Scott King has joined the leadership team as Vice President of Regulatory Affairs. ABS is a clinical stage, medical device company whose stenting platform overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties Mr. King will direct ABS’s […]
Published: Jan 05, 2018 Los Angeles, California, November 26, 2017 – Advanced Bifurcation Systems announced that is it seeking $20 million in new funding from outside investors. The new goal was announced in conjunction with the appointment of new CFO Ken Richards, who brings with him a strong background in both debt and equity financing. With a […]
LOS ANGELES, Oct. 03, 2017 (GLOBE NEWSWIRE) — Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company is planning to undertake human clinical trials in […]
